Anixa Biosciences ANIX
NASDAQ ANIX
$2.77 -0.16 (-5.46%)
At close: Oct 1, 2026 · 4:00 PM EDT

Anixa Biosciences (ANIX) Total Non-Current Liabilities (2010 - 2017)

Updated

Anixa Biosciences (ANIX) posted Total Non-Current Liabilities of $3.72 million for fiscal Q1 2017 (quarter ended Jan 31, 2017), up 199.4% from $1.24 million a year earlier and up 694.4% from the prior quarter.

Analysis

Anixa Biosciences (ANIX) Total Non-Current Liabilities (2010 - 2017) Analysis & Trends

At the end of FY2016 (ended Oct 31, 2016), Anixa Biosciences' Total Non-Current Liabilities came in at $468,756, down 21.1% from FY2015.

  • Annual Total Non-Current Liabilities has declined for three consecutive fiscal years, with a five-year compound annual growth rate of -28.9% (FY2011 to FY2016).
  • In prior fiscal years, Anixa Biosciences' Total Non-Current Liabilities was $593,782 in FY2015 (-67.2%), $1.81 million in FY2014 (-51.9%), $3.76 million in FY2013 (+102.7%) and $1.85 million in FY2012 (-28.3%).
  • The fiscal Q1 2017 figure stands as the highest quarterly Total Non-Current Liabilities since fiscal Q3 2014.
  • On a year-over-year basis, Total Non-Current Liabilities increased in two of the last eight quarters, with an average decline of 15.5%.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was fiscal Q1 2014, with growth of 226.7%; the weakest was fiscal Q2 2015, with a decline of 94.4%.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior fiscal quarters was $468,756 (Q4 2016), $531,624 (Q3 2016) and $706,930 (Q2 2016).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Anixa Biosciences 101.33 Mn 100.06 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2017 3.72 Mn
Oct 31, 2016 468,756.00
Jul 31, 2016 531,624.00
Apr 30, 2016 706,930.00
Jan 31, 2016 1.24 Mn
Oct 31, 2015 593,782.00
Jul 31, 2015 711,666.00
Apr 30, 2015 688,676.00
Jan 31, 2015 1.67 Mn
Oct 31, 2014 1.81 Mn
Jul 31, 2014 10.11 Mn
Apr 30, 2014 12.31 Mn
Jan 31, 2014 12.57 Mn
Oct 31, 2013 3.76 Mn
Jul 31, 2013 3.55 Mn
Apr 30, 2013 3.80 Mn
Jan 31, 2013 3.85 Mn
Oct 31, 2012 1.85 Mn
Jul 31, 2012 1.78 Mn
Apr 30, 2012 2.13 Mn
API Access

Anixa Biosciences Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ANIX&period=max&api_key=YOUR_API_KEY